ADS Clinical Symposium: Multifactor interventions improving diabetes outcomes
Tracks
Breakout 1: Arena 1
Wednesday, August 20, 2025 |
11:00 AM - 1:00 PM |
Arena 1 |
Speaker
Prof Alicia Jenkins
Lipids
11:00 AM - 11:30 AMBiography
Dr Sonali Gnanenthiran
Senior Research Fellow, Cardiovascular
The George Institute for Global Health
Hypertension
11:30 AM - 12:00 PMBiography
Dr Sonali Gnanenthiran (MBBS [Hons I], PhD, FRACP, FCSANZ) is a cardiologist at The George Institute for Global Health and Concord Hospital, Australia. Her clinical and research interests include cardiovascular disease prevention and risk assessment. She completed a PhD with the University of Sydney. She was a recipient of the John Chalmers Fellowship at The George Institute, and a Heart Foundation post-doctoral fellowship. She has >50 publications and has been awarded >$18.5 million in research funding. She has been awarded the 2023 American Heart Association Karl Link Award for Thrombosis, 2022 American Heart Association Paul Dudley White International Scholar Award, 2021 Scientific Medal of the Thrombosis and Haemostasis Society of Australia and New Zealand, 2020 American Heart Association Paul Dudley White International Scholar Award, and 2018 Best Poster Presentation at the European Society of Cardiology scientific meeting.
Assoc Prof (Peter) Shane Hamblin
Head of Endocrinology & Diabetes
Western Health
Glucose lowering therapies
12:00 PM - 12:30 PMBiography
Assoc Prof Neale Cohen
Director Clinical Services
Baker Heart And Diabetes Institute
Role for intensive lifestyle interventions
12:30 PM - 1:00 PMBiography
Neale Cohen is currently the Director of Clinical Services at the Baker Heart and Diabetes Institute in Melbourne. He is an endocrinologist practicing at the Baker Institute in Melbourne. He is responsible for the management of one of Australia’s largest Melbourne based diabetes services, with additional services in Footscray and a Victorian Telehealth service. He is an Associate Professor at University of Queensland and Monash University. His clinical research interests and publications include diabetes technology, diabetes therapeutics and indigenous diabetes.
